Media center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Director of Global Strategic Communications:
David Verga

Email: media@path.org

Recent Press Coverage

  1. Nikolaj Gilbert, President and CEO of PATH, shares insights on the growing trend of global health organizations appointing Chief AI Officers (CAIOs) to harness the transformative potential of artificial intelligence in healthcare.
    Published: September 2024
  2. The first vaccine for malaria received major regulatory approval in 2015. It didn’t become part of vaccination programs in Africa until 2024. PATH's Ashley Birkett speaks about the manufacturing plans that GSK had put in place were derailed.
    Published: July 2024
  3. Neeraj Jain, PATH’s Country Director for India, speaks on the role of technology in revolutionizing health care, improving outcomes, and driving medical research in India.
    Published: June 2024
  4. PATH’s Regional Director for Advocacy and Public Policy discusses her critical work advancing policies that improve primary health care outcomes for women and girls.
    Published: May 2024

We develop evidence-based expertise and resources

Our global team leverages data and evidence to develop resources and innovations that bring good health to more people.

Explore our evidence

Join the latest discussions on health equity.

We partner with the public and private sector, government, and academia from around the world to share insightful conversations on the latest topics affecting health equity.

Explore PATH events

PATH Newsroom

Related articles

Read our latest

971 Item s
971 Item s
    Date
    From
    To
  1. PATH, as a major sub-partner on the consortium led by FHI360, launches the STRengthening Infectious disease DEtection Systems (STRIDES) Activity: a new Activity funded by USAID to combat epidemics, pandemics, and novel infectious disease threats.
    Published: November 2024
    Press Release
  2. Published: October 2024
    Announcement
  3. The trial aimed to determine how well a new, injectable, non-replicating rotavirus vaccine candidate works, compared to a licensed oral rotavirus vaccine in preventing infant diarrhea.
    Published: October 2024
    Announcement
  4. Published: October 2024
    Announcement
  5. Published: October 2024
    Press Release